Contraceptive prevalence, any modern method in Estonia
Estonia: Contraceptive prevalence, any modern method was 60.9% in 2014. ▲ Rising
Contraceptive prevalence, any modern method in Estonia, 1994–2014
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Estonia is 60.9%, measured in 2014. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 5.2% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Estonia peaked at 60.9% in 2014 and was at its lowest, 43.9%, in 1994.
Estonia ranks 25th of 113 countries on this measure, in the top quarter.
Contraceptive prevalence, any modern method in Estonia, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1994 | 43.9% | — |
| 2005 | 57.9% | +31.7% |
| 2006 | 52.6% | -9.2% |
| 2010 | 54.8% | +4.2% |
| 2014 | 60.9% | +11.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 43.9% | 43.9% | 43.9% | 1 |
| 2000s | 55.2% | 52.6% | 57.9% | 2 |
| 2010s | 57.8% | 54.8% | 60.9% | 2 |
Countries ranked near Estonia
More health data for Estonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.02 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,416 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.8 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Estonia?
- Contraceptive prevalence, any modern method in Estonia was 60.9% in 2014, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Estonia?
- The highest recorded value was 60.9% in 2014.
- What is the lowest contraceptive prevalence, any modern method recorded in Estonia?
- The lowest recorded value was 43.9% in 1994.
- How does Estonia rank for contraceptive prevalence, any modern method?
- Estonia ranks 25th out of 113 countries with data for 2014.
- Is contraceptive prevalence, any modern method rising or falling in Estonia?
- Over the last ten years it is up 5.2%. The long-run trend across the full record is rising.
- Where does this Estonia data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.